Next Generation News and Research

RSS

Cerner, MedAssets announce reseller agreement to increase revenue capture

Cerner Corporation and MedAssets announced a reseller agreement that increases the interoperability of Cerner's revenue cycle offerings and gives Cerner clients access to a broader suite of solutions to increase revenue capture, accelerate cash flow and reduce administrative costs.

12 Oct 2010

New phase 2 study shows first-line promise of lung cancer drug PF-299

A new-generation lung cancer drug has shown an impressive ability to prevent disease progression when administered as a first-line treatment in patients with advanced disease, investigators reported at the 35th Congress of the European Society for Medical Oncology (ESMO).

11 Oct 2010

ImaginAb and Imanet enter master service agreement for pre-clinical and clinical imaging

ImaginAb, Inc. and Imanet have signed a master service agreement for pre-clinical and clinical imaging. This agreement supports the development strategy for ImaginAb's pipeline of next generation diagnostic imaging agents based on recombinant antibody fragments. The Imanet™ network of Positron Emission Tomography (PET) imaging sites provides assistance in all aspects of PET imaging-based clinical trials: from proof-of-concept radiochemistry to clinical imaging, with more than 40 PET research tracers.

11 Oct 2010

TruTouch secures grant to accelerate development of next-generation technology platform

TruTouch Technologies, a pioneer in non-invasive biometric intoxication detection systems, today announced that it has secured a $438,000 grant to accelerate the development of its next-generation technology platform.

11 Oct 2010

Genentech initiates GDC-0449 Phase II clinical trial in BCC patients

Curis, Inc. a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that its collaborator Genentech, a member of the Roche Group, has initiated a Phase II clinical trial of GDC-0449, an orally-administered small molecule Hedgehog Pathway Inhibitor, as a single-agent therapy for patients with operable basal cell carcinoma (BCC).

11 Oct 2010

FDA approves Warner Chilcott's ACTONEL for postmenopausal osteoporosis

Warner Chilcott plc today announced that the United States Food and Drug Administration (FDA) has approved its next generation ACTONEL® (risedronate sodium) product for the treatment of postmenopausal osteoporosis in the United States. The product will be marketed as ATELVIA™ (risedronate sodium) delayed-release tablets.

11 Oct 2010

IntegenX receives DTRA contract to develop ISS system for rapid detection of emerging pathogens

IntegenX, Inc. today announced that it has been awarded a new contract by the Defense Threat Reduction Agency (DTRA) of the U.S. Department of Defense (DoD) to develop an Integrated Sample-to-Sequence (ISS) system for rapid detection and identification of genetically engineered bacteria and viruses, medically relevant bacteria and viruses, and emerging pathogens.

11 Oct 2010

Presbyterian Hospital collaborates with New York Center for Autism to establish Institute for Brain Development

NewYork-Presbyterian Hospital, along with its affiliated medical schools Columbia University College of Physicians and Surgeons and Weill Cornell Medical College, announced its collaboration with the New York Center for Autism to establish the Institute for Brain Development, a comprehensive, state-of-the-art institute dedicated to addressing the pressing clinical needs of individuals living with autism spectrum disorders and other developmental disorders of the brain, across their lifespan.

8 Oct 2010

Hard combat can devastate veterans until old age

The trauma from hard combat can devastate veterans until old age, even as it influences others to be wiser, gentler and more accepting in their twilight years, a new University of Florida study finds.

8 Oct 2010

AnalizaDx SIA technology, Nanosphere Verisens assay effective for prostate cancer diagnosis

At the annual meeting of the North-Central American Urological Association, Mark Stovsky, MD, Case Western Reserve University School of Medicine Case Medical Center, and principal investigator, presented positive data combining the AnalizaDx SIA technology with the Nanosphere Verisens ultra-sensitive PSA assay.

7 Oct 2010

Viking Systems launches Next Generation 3DHD Visualization System

Viking Systems, Inc. reported today that it officially launched its Next Generation 3DHD Visualization System on October 4, 2010 at the American College of Surgeons Clinical Congress (ACS) held October 3-7 in Washington, DC. The Company also announced today its first distribution partners for the new system.

7 Oct 2010

UEM, San Diego School of Medicine enter partnership to address medical human resource needs in Mozambique

Aimed at enhancing the capacity of Mozambique's flagship medical school, Universidade Eduardo Modlane (UEM), in pre- and postgraduate medical education, the University of California, San Diego School of Medicine and UEM entered into a partnership in 2007 to address both short and long-term medical human resource needs in Mozambique.

7 Oct 2010

Synthetic Genomics, JCVI announce formation of new company to develop next generation vaccines

The company Synthetic Genomics Inc. (SGI) and the not-for-profit research organization, the J. Craig Venter Institute (JCVI) today announced the formation of a new company, Synthetic Genomics Vaccines Inc. (SGVI).

7 Oct 2010

SOKO signs revenue-sharing agreement with Bin Xian for education offering

SOKO Fitness & Spa Group, Inc., an operator of fitness centers, beauty salons and spas in Northeast China as well as suburban Beijing, today announced that it has signed a cooperation and revenue-sharing agreement with Bin Xian Vocational Technology and Education Center ("Bin Xian"), which is located in suburban Harbin, China.

6 Oct 2010

UCLA-led consortium receives $9.9M to compare wireless and telephone management after hospitalizations

A UCLA-led consortium of five University of California medical schools, plus Cedars-Sinai Medical Center in Los Angeles, has received $9.9 million from the U.S. Department of Health and Human Services' Agency for Healthcare Research and Quality to research the use of wireless and telephone care management to reduce hospital readmissions for heart failure patients.

6 Oct 2010

Accuray receives SBIR grant to develop high-energy X-ray source for Homeland Security applications

Accuray Incorporated, a global leader in the field of radiosurgery, announced today that the company was awarded a $1 million Small Business Innovation Research (SBIR) grant by the U.S. Government to be used toward further development of a high-energy X-ray source for Homeland Security applications.

6 Oct 2010

FDA grants orphan drug designation to hGH-CTP for treating growth hormone deficiency

PROLOR Biotech, Inc., a company developing next generation biobetter therapeutic proteins, today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to hGH-CTP, PROLOR's longer-acting version of human growth hormone for the treatment of growth hormone deficiency.

5 Oct 2010

NIH awards contract to develop nanotechnology tools for atherosclerosis treatment

Georgia Tech and Emory University have received a five-year $14.6 million contract from the National Institutes of Health (NIH) to continue the development of nanotechnology and biomolecular engineering tools and methodologies for detecting and treating atherosclerosis.

5 Oct 2010

HHS announces $473 million grant to help people make effective healthcare decisions

HHS' Agency for Healthcare Research and Quality today announced the award of $473 million in grants and contracts to support projects that will help people make health care decisions based on the best evidence of effectiveness. The funding announced today covers all of AHRQ's allocation and $173 million administered for the HHS Secretary by AHRQ.

1 Oct 2010

Agilent introduces SureSelect Kinome Target Enrichment Kit to focus next-generation sequencing studies

Agilent Technologies Inc. today introduced the SureSelect Kinome Target Enrichment Kit, enabling researchers to focus next generation sequencing studies on expressed kinases (the kinome). Researchers increasingly are looking at human kinases as a rich, proven source of biomarkers as well as potential drug targets for cancers and other diseases.

30 Sep 2010

Next Generation News and Research

Cerner, MedAssets announce reseller agreement to increase revenue capture

New phase 2 study shows first-line promise of lung cancer drug PF-299

ImaginAb and Imanet enter master service agreement for pre-clinical and clinical imaging

TruTouch secures grant to accelerate development of next-generation technology platform

Genentech initiates GDC-0449 Phase II clinical trial in BCC patients

FDA approves Warner Chilcott's ACTONEL for postmenopausal osteoporosis

IntegenX receives DTRA contract to develop ISS system for rapid detection of emerging pathogens

Presbyterian Hospital collaborates with New York Center for Autism to establish Institute for Brain Development

Hard combat can devastate veterans until old age

AnalizaDx SIA technology, Nanosphere Verisens assay effective for prostate cancer diagnosis

Viking Systems launches Next Generation 3DHD Visualization System

UEM, San Diego School of Medicine enter partnership to address medical human resource needs in Mozambique

Synthetic Genomics, JCVI announce formation of new company to develop next generation vaccines

SOKO signs revenue-sharing agreement with Bin Xian for education offering

UCLA-led consortium receives $9.9M to compare wireless and telephone management after hospitalizations

Accuray receives SBIR grant to develop high-energy X-ray source for Homeland Security applications

FDA grants orphan drug designation to hGH-CTP for treating growth hormone deficiency

NIH awards contract to develop nanotechnology tools for atherosclerosis treatment

HHS announces $473 million grant to help people make effective healthcare decisions

Agilent introduces SureSelect Kinome Target Enrichment Kit to focus next-generation sequencing studies

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News